Enovis Corporation (ENOV)

Enovis Corporation (ENOV) is a healthcare company (medical devices) based in the United States. The share price is $27.54, down 1.38% on the day, which values the company at $1.59B. Price as of 17 Nov 2026, 17:30 UTC, from Yahoo Finance.

Key facts

Share price
$27.54−1.38% today
Market value
$1.59B
Forward P/E
7.9×
Funk Score
32/100
Against its own history
Below its usual priceusual price $31.63
200-week average
$40.9333% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Enovis Corporation in more detail

ENOV trades at 7.9× next year's expected earnings, 0.7× sales. Measured against its own history, the price is 13% below what its usual multiples would imply ($31.63) — below its usual price. It sits 33% below its 200-week average of $40.93.

Over the last five fiscal years Enovis Corporation has compounded revenue 14.9% a year, free cash flow -36.1% a year. Its Funk Score is 32 out of 100 (financial strength 1.2, profitability 2.7, growth 6.2, value 2.9, each out of 10).

In its favour: Five straight years of revenue growth. Worth checking: Altman Z in the distress zone; Share count keeps rising.

1 of the superinvestors tracked here hold ENOV, including Mason Hawkins (0.0% of the portfolio).

Superinvestors holding ENOV

1 of the investors tracked here report a position in their latest 13F filing.

Enovis Corporation (ENOV): questions and answers

What is ENOV's PEG ratio?

Enovis Corporation's PEG ratio is 3.45 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Enovis Corporation's market cap?

Enovis Corporation is valued at $1.59B at a share price of $27.54.

Is ENOV overvalued or undervalued?

Against its own history, ENOV is below its usual price: the price is 13% below the $31.63 implied by the median multiples it has traded at (price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is ENOV above its 200-week moving average?

No. ENOV is 32.7% below its 200-week average of $40.93. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Enovis Corporation growing?

Over the last five fiscal years Enovis Corporation's revenue grew 14.9% a year; over ten years revenue grew -4.1% a year.

Does ENOV pay a dividend?

Enovis Corporation does not currently pay a regular dividend.

Cite this page

Funkfolio, “Enovis Corporation (ENOV) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ENOV

Underlying data: Yahoo Finance; company filings with the SEC.